ImageneBio, Inc. (IMA)

Last Closing Price: 3.81 (2026-11-18)

Stock-Based Compensation (Quarterly)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

ImageneBio, Inc. (IMA) had Stock-Based Compensation of $3.45M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-15.62M
--
--
$17.31M
$-17.31M
$1.71M
$-15.60M
$-15.60M
$-15.62M
$-15.62M
$-15.62M
$-15.62M
$-17.31M
$-17.14M
17.12M
17.12M
$-0.91
$-0.91
Balance Sheet Financials
$130.60M
--
$11.94M
$142.54M
$8.07M
--
$6.33M
$14.40M
$128.14M
$128.14M
$128.14M
12.99M
Cash Flow Statement Financials
$-33.39M
$-1.17M
$24.89M
$94.53M
$84.85M
$-9.68M
Stock-Based Compensation
$3.45M
--
--
Fundamental Metrics & Ratios
16.17
--
--
--
--
--
--
--
--
--
--
$-33.39M
--
--
--
--
--
--
--
-12.19%
-12.19%
-10.96%
-12.19%
$9.87
$-1.95
$-1.95